• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在手术六小时内停用坎格雷洛后对左回旋支近端进行紧急血运重建

Urgent Revascularization of the Left Proximal Circumflex Following Cessation of Cangrelor Within Six Hours of Procedure.

作者信息

Huang Sherri, Rodriguez Camilo, Shakfeh Khalid, Smith Jorden, Reddy Koushik

机构信息

Internal Medicine and Pediatrics, University of South Florida Morsani College of Medicine, Tampa, USA.

Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.

出版信息

Cureus. 2023 Jun 12;15(6):e40314. doi: 10.7759/cureus.40314. eCollection 2023 Jun.

DOI:10.7759/cureus.40314
PMID:37448385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10337834/
Abstract

Patients undergoing procedures are often transitioned off anticoagulants using anti-platelet agents with short half-lives as a "bridge." We present the case of a patient with a history of in-stent thromboses who experienced a thrombotic event following a literature-guided bridging protocol. This case is one of the first to show that stopping cangrelor within six hours led to a need for urgent revascularization and suggests that the timing for discontinuing bridging agents should be customized based on the patient's history of increased blood clotting.

摘要

接受手术的患者通常会使用半衰期短的抗血小板药物作为“桥梁”,从抗凝药物过渡下来。我们报告了一例有支架内血栓形成病史的患者,该患者在遵循文献指导的桥接方案后发生了血栓事件。该病例是首批表明在六小时内停用坎格雷洛导致需要紧急血运重建的病例之一,并提示应根据患者血液凝固增加的病史来定制停用桥接药物的时机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70a0/10337834/d3f9276e1d96/cureus-0015-00000040314-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70a0/10337834/d3f9276e1d96/cureus-0015-00000040314-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70a0/10337834/d3f9276e1d96/cureus-0015-00000040314-i01.jpg

相似文献

1
Urgent Revascularization of the Left Proximal Circumflex Following Cessation of Cangrelor Within Six Hours of Procedure.在手术六小时内停用坎格雷洛后对左回旋支近端进行紧急血运重建
Cureus. 2023 Jun 12;15(6):e40314. doi: 10.7759/cureus.40314. eCollection 2023 Jun.
2
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review.围手术期使用坎格瑞洛进行抗血小板桥接:一项队列研究和叙述性综述。
Ann Pharmacother. 2023 May;57(5):544-552. doi: 10.1177/10600280221120310. Epub 2022 Aug 24.
3
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience.冠状动脉支架植入术后接受手术患者使用坎格雷洛的抗血小板治疗:一项真实世界桥接方案经验
TH Open. 2020 Dec 23;4(4):e437-e445. doi: 10.1055/s-0040-1721504. eCollection 2020 Oct.
4
Feasibility and Safety of Bridging Antiplatelet Therapy with Cangrelor in Neuro-Oncology: A Preliminary Experience.坎格雷洛用于神经肿瘤学桥接抗血小板治疗的可行性与安全性:初步经验
J Neurol Surg A Cent Eur Neurosurg. 2025 Jan;86(1):105-109. doi: 10.1055/s-0044-1785649. Epub 2024 Apr 15.
5
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.抗血小板治疗桥接应用坎格雷洛在冠状动脉支架置入患者中的病例系列研究。
Ann Pharmacother. 2019 Feb;53(2):171-177. doi: 10.1177/1060028018795840. Epub 2018 Aug 22.
6
A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent.一种针对近期接受冠状动脉支架置入术并即将接受非心脏手术患者的新型桥接策略。
Cardiol Ther. 2018 Dec;7(2):209-213. doi: 10.1007/s40119-018-0113-2. Epub 2018 Jul 11.
7
Cangrelor use prior to left ventricular assist device surgery: a case series.在左心室辅助装置手术前使用坎格雷洛:病例系列。
J Thromb Thrombolysis. 2018 Aug;46(2):131-133. doi: 10.1007/s11239-018-1691-5.
8
Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug-Eluting Stent Who Developed Acute Tirofiban-Related Thrombocytopenia.在近期接受药物洗脱支架治疗且发生急性替罗非班相关性血小板减少症的患者中,使用坎格瑞洛作为左心室辅助装置植入的桥接治疗。
Pharmacotherapy. 2019 Apr;39(4):521-525. doi: 10.1002/phar.2219. Epub 2019 Mar 4.
9
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.缺血事件在接受经皮冠状动脉介入治疗的患者中发生较早,并可通过坎格瑞洛减少:来自 CHAMPION PHOENIX 的研究结果。
Circ Cardiovasc Interv. 2022 Jan;15(1):e010390. doi: 10.1161/CIRCINTERVENTIONS.120.010390. Epub 2021 Dec 17.
10
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series.新型药物坎格雷洛联合肝素在需要心血管手术的肝素诱导血小板减少症患者体外循环中的应用:病例系列研究。
Semin Thorac Cardiovasc Surg. 2020;32(4):763-769. doi: 10.1053/j.semtcvs.2019.10.002. Epub 2019 Oct 11.

本文引用的文献

1
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.经皮冠状动脉介入治疗后的桥接抗血小板治疗:JACC本周综述主题
J Am Coll Cardiol. 2021 Oct 12;78(15):1550-1563. doi: 10.1016/j.jacc.2021.08.013.
2
Complications and Management of Eptifibatide-Induced Thrombocytopenia.依替巴肽诱导的血小板减少症的并发症和处理。
Ann Pharmacother. 2021 Dec;55(12):1467-1473. doi: 10.1177/10600280211006645. Epub 2021 Apr 3.
3
How to Manage the Perioperative Patient on Combined Anticoagulant and Antiplatelet Therapy: Comments on the 2020 ACC Consensus Decision Pathway.
如何管理接受联合抗凝和抗血小板治疗的围手术期患者:对2020年美国心脏病学会共识决策路径的评论
J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1561-1564. doi: 10.1053/j.jvca.2021.01.042. Epub 2021 Jan 29.
4
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience.冠状动脉支架植入术后接受手术患者使用坎格雷洛的抗血小板治疗:一项真实世界桥接方案经验
TH Open. 2020 Dec 23;4(4):e437-e445. doi: 10.1055/s-0040-1721504. eCollection 2020 Oct.
5
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.2020年美国心脏病学会解决方案集监督委员会报告:经皮冠状动脉介入治疗或患有动脉粥样硬化性心血管疾病的心房颤动或静脉血栓栓塞患者的抗凝和抗血小板治疗专家共识决策路径
J Am Coll Cardiol. 2021 Feb 9;77(5):629-658. doi: 10.1016/j.jacc.2020.09.011. Epub 2020 Nov 26.
6
Use of Intravenous Cangrelor as Antiplatelet Bridge Therapy in a Patient Undergoing Esophageal Dilation Procedure.经静脉使用坎格雷洛作为抗血小板桥接治疗在接受食管扩张术的患者中的应用。
Cardiovasc Revasc Med. 2020 Nov;21(11S):94-95. doi: 10.1016/j.carrev.2019.12.036. Epub 2020 Jan 7.
7
Cangrelor Bridging Within 6 Months of a Drug-Eluting Stent in a Patient for Emergency Cervical Spine Surgery: A Case Report.替卡格雷在药物洗脱支架植入6个月内用于一名患者进行急诊颈椎手术的桥接治疗:一例报告
A A Pract. 2019 Jul 15;13(2):69-73. doi: 10.1213/XAA.0000000000000994.
8
A Case Report of Cangrelor Bridge Therapy for a Diagnostic Bronchoscopy With Biopsy.Cangrelor 桥接治疗用于诊断性支气管镜检查和活检的病例报告。
J Pharm Pract. 2020 Apr;33(2):231-235. doi: 10.1177/0897190018795343. Epub 2018 Aug 23.
9
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.抗血小板治疗桥接应用坎格雷洛在冠状动脉支架置入患者中的病例系列研究。
Ann Pharmacother. 2019 Feb;53(2):171-177. doi: 10.1177/1060028018795840. Epub 2018 Aug 22.
10
A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent.一种针对近期接受冠状动脉支架置入术并即将接受非心脏手术患者的新型桥接策略。
Cardiol Ther. 2018 Dec;7(2):209-213. doi: 10.1007/s40119-018-0113-2. Epub 2018 Jul 11.